Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB

Today, on 11 June 2024, the Annual General Meeting of Diagonal Bio AB was held. A summary of the adopted resolutions follows below.Resolution on adoption of the accounts and appropriation of profit The Annual General Meeting resolved to adopt the income statement and the balance sheet. The Annual General Meeting also resolved to dispose of the company’s profit in accordance with the board’s proposal, meaning that no dividend will be paid and that available funds will be carried forward. Discharge from liability for the members of the board of the directors and the CEO The Annual

Read original

Addtech acquires C. Gunnarssons Verkstads AB

Addtech Industrial Solutions, a business area in the Addtech Group, has today signed an agreement to acquire 89 % of the shares outstanding in C. Gunnarssons Verkstads AB (“CGV”). CGV is a leading supplier on the Nordic market of machines and production lines for lumber handling. CGV is project company with 45 employees and an average annual turnover of approximately SEK 200 million with headquarters in Vislanda, Sweden. CGV becomes a part of and complements our operations within the Material Processing business unit and strengthens our offer to the forest industry. Closing will

New doping test can reveal more cheating female athletes

Roughly three times as many male athletes are banned for doping as female. A new doctoral thesis from Karolinska Institutet shows that one possible reason for this is that the doping tests in use fail to take account of women’s varying hormone profile. Instead, an alternative is proposed that includes a blood test and a limit value that allows doping tests for both elite athletes and casual sportspersons.Despite the debate of recent years on testosterone levels in elite female athletes, there are only a handful of scientific studies on the topic. However, Jona Elings Knutsson’s doctoral

#24-65 Eyeonid Group has changed its name to Eyeon Group

Eyeonid Group, whose share are listed on NGM, has changed its name to Eyeon Group. New Listing name and FISN-code will be entered in the trading system from June 13, 2024. All other instrument information will remain unchanged.   Information regarding the affected instruments:   New Listing name: Eyeon Group Exchange symbol: EOID ISIN-code: SE0019763988 CFI-code: ESVUFR New FISN-code: EYEONGROUP/SH Instrument-ID: 3EBY Market-ID: NSME Segment-ID: NSSE   For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se

Storebrand ASA – Successful placement of senior unsecured bonds

Storebrand ASA has today issued a new NOK 500 million 5-year bond issue with floating rate coupon of 3 months Nibor +0.92% p.a. The proceeds from the bond issue will be used for general corporate purposes and the bonds will be applied for listing on Nordic ABM. Danske Bank and SEB acted as Joint Lead Managers for the transaction. For further information, please contact: Nikola Heitmann, Head of Capital Management, tel.: +47 416 97 236 Kjeil R. Krøkje, Head of Finance, Strategy and M&A, tel.: +47 934 12 155

New publications in peer-reviewed scientific journals support the potential for OXC-101 as a novel anti-cancer therapy

OXC-101 shows promise in enhancing the effectiveness of immune checkpoint inhibitors. The article published in Oncogenesis by Helleday laboratory, Karolinska Institute, and Oxcia team suggests that the mitotic MTH1 inhibitor OXC-101 (TH1579) has the potential to enhance the effectiveness of immune checkpoint inhibitors (ICI) in cancer treatment. This is achieved by influencing immune checkpoint-related proteins and pathways (1). The researchers discovered that treatment with OXC-101 leads to an increase in PD-L1 expression and inflammatory response in cancer cell lines. This finding may

Swedish Island Hotel Fights for Marine Protection with Innovative AI Project

Pater Noster, a renowned boutique hotel and former island lighthouse previously used to protect sailors from harm, is now extending that protection to the very ocean that surrounds it.   Photo Credits: Erik Nissen Johansen/Westsweden.com (Download )   Pater Noster is proud to announce its pioneering sponsorship of Green Cubes , a Greentech initiative aimed at combating ocean acidification. This summer, the hotel also hosts the "Art & Science of

#24-64 Information regarding the last day of trading in paid subscribed shares in Latvian Forest Company AB

The rights issue in Latvian Forest Company AB is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed shares has been set for June 14, 2024. Information regarding the affected instrument:   Listing name: Latvian Forest Company BTB Exchange symbol: LATF BTB ISIN-code: SE0021923067 CFI-code: ESNUFR FISN-code: LATVIANFOR/SH B Last day of trading: 2024-06-14 Instrument-ID: ETT9 Market-ID: NSME Segment-ID: NSSE   For more information about this Market Notice, please contact us by e-mail,

IFS to acquire Copperleaf

Expanding customer value through Copperleaf’s Advanced Decision Analytics Software for Asset-Intensive Industries and IFS’s Leadership in Enterprise Asset ManagementLondon, UK – June 11[th], 2024 - IFS, the leading technology innovator in cloud and Industrial AI software, today announces it has entered into a definitive agreement to buy Copperleaf Technologies Inc. (TSX: CPLF). As the most advanced provider of AI-powered enterprise Asset Investment Planning and Management (“AIPM”) software, Copperleaf offers compelling capabilities that add further depth to IFS’s position as the foremost

Fossil-free beef production that reaches climate goals for 2030 already today

Lantmännen, together with the partner farm “Hagshultskossornas Kopensionat”, is now releasing a new report. The calculations show that the Småland farm's beef production already today reaches the Science Based Targets FLAG target for 2030, which follows the emission reduction rate required to reach the goal of the Paris Agreement. Hagshult's “Kopensionat” in Skillingaryd, Småland, uses retired dairy cows in a unique business model in Sweden where the cows' lifespan is extended. Through a focus on productivity, resource efficiency and fossil-free inputs, the climate footprint of beef

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Nightingale Health Plc Company release 11 June 2024 at 2:50 p.m. (EEST)   The Board of Directors of Nightingale Health Plc (“Nightingale Health”) has in its meeting on 20 May 2024, approved request of shareholders to convert 806,680 Series A shares to Series B shares in accordance with Article 5 in the Articles of Association. As a result of conversion of shares, the number of the Nightingale Health’s Series A shares is 19,779,244, Series B shares is 40,040,415 and EMP shares is 1,098,800. The conversion does not affect the total amount of shares which is 60,918,459. The

The Board of Directors of Ponsse Plc decided on new performance periods of share-based incentive plans

Ponsse PlcOther information disclosed according to the rules of the ExchangeJune 11, 2024, AT 2.45 PM  The Board of Directors of Ponsse Plc established two share-based incentive plans for the CEO and key employees of the group in 2023. The key terms of the incentive plans were published in a stock exchange release on 3 March 2023. The Board of Directors of Ponsse Plc decided on new performance periods for the share-based incentive plans of the group. The CEO Performance-Based Share Ownership Plan, Performance Period 2024—2026 During the performance period 2024-2026 of the CEO

Bulletin from the annual general meeting of Quartiers Properties AB (publ), June 11, 2024

At the annual general meeting (the “AGM”) of Quartiers Properties AB (publ) (the "Company"), held today on June 11, 2024, the following resolutions were passed with the required majority.Adoption of the income statement and balance sheet The AGM adopted the income statement and balance sheet as well as the consolidated income statement and balance sheet for the fiscal year of 2023. Dividend on preference shares The AGM resolved, in accordance with the board's proposal, on a dividend, in accordance with the Company's articles of association, of SEK 0.96 per preference share (which

Parking labelled ‘biggest stressor’ for driving football fans on game days, ahead of 2024 Euros

One in four European football fans have experienced spending over 20 minutes searching for a parking space.As the 2024 European Football Championship launches this week in Germany, it is not only the final scores that are set to have fans on the edge of their seats. New research into the driving experiences of fans across Europe has revealed that on regular match days over one third (36%) consider finding somewhere to park close to the stadiums a key stressor.  The findings – following research amongst driving football fans from the global parking solution provider EasyPark Group –

Very High Willingness to Pay for Zeqmelit® According to Publication in International Scientific Journal

The esteemed scientific journal, Journal of Health Economics and Outcomes Research, has published an article on the willingness to pay among Swedish patients with acute allergic reactions for a medication like Zeqmelit®. This means that two independent international journals have now published results showing both a significant patient need for Zeqmelit® and a strong willingness to pay for the medication among patients.In collaboration with IHE, the Institute for Health Economics, AcuCort conducted a survey study among over 400 patients in Sweden who have experienced acute allergic

Listing prospectus for CapMan's EUR 60 million sustainability-linked notes available; listing application submitted

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. CapMan PlcStock Exchange Release11 June 2024 at 14:00 EEST Listing prospectus for CapMan's EUR 60 million sustainability-linked notes available; listing application submitted CapMan plc (the “Company”) announced on 3 June 2024 its decision to issue new unsecured sustainability-linked notes in

Peab expands E20 between Götene and Mariestad

Peab has been commissioned to expand E20 at Mariestad and put in a central barrier. The customer is the Swedish Transport Administration and the contract is worth SEK 848 million.The project involves rebuilding E20 from the current motorway section at Götene to west of the Haggården interchange at Mariestad. The new 20 kilometer stretch will be a 2+2 lane road with a central barrier and an overpass at of the Lugnås interchange. Bearing capacity is low in places in the existing road and it is not fully dimensioned for heavy vehicles. There have also been problems with frost heaving, which

iLOQ establishes new distribution center in Dallas, USA

iLOQ's new distribution center in Dallas supports the company’s strategic growth plan. Located in Dallas, Texas, the new partner operated facility is the first distribution center for iLOQ in North America. It will enable the company to better manage deliveries to meet the demand of its customers throughout the USA and Canada. As well as supporting iLOQ’s strategic growth plan in North America, the new distribution center will also release capacity from other locations allowing them to better serve additional growth of other markets. The implementation of dedicated supply

The Board of Directors and management sign in addition to subscription commitments

NextCell Pharma AB (publ) ("NextCell" or the "Company") carries out a rights issue of units of up to approximately SEK 40.1 million, which is covered to approximately 100 percent by subscription and guarantee commitments. The company's Board of Directors, management and key employees, who have previously entered into subscription commitments of up to a total of approximately SEK 1.5 million, have now announced that they will register their interest in subscribing for units for a total of approximately SEK 3.3 million, corresponding to 8.2 percent of the rights issue.In addition to the

Lea bank ASA – Swedish banking license granted

Reference is made to the stock exchange announcement from January 31, 2024, where the bank reported that they were applying for a Swedish Banking License through a Swedish subsidiary (to be renamed, Lea Bank AB) fully owned by Lea bank ASA. The subsidiary has today received notice from the Swedish Financial Supervisory Authority (SFSA) that a banking license has been granted according to the Banking and Financing Business Act (3 kap. 2 § lagen (2004:297) om bank- och finansieringsrörelse) The banking license has been granted subject to the following conditions: · The licence must

Ponsse to change segment reporting

Ponsse PlcOther information disclosed according to the rules of the ExchangeJune 11, 2024, AT 13.55 PMPonsse has updated its global operating model, with the new model having entered into force on 1 June 2024. A shift to a global organisational structure and reporting guidelines is a key part of the new operating model. The new operating model enables a customer-driven organisation focused on sales and maintenance services, divided into five market areas. From 1 June 2024, the company’s market areas are: 1) Nordic countries and the Baltics; 2) Europe; 3) North America; 4) South

Biosergen receives the final permission required to test lead candidate BSG005 in patients with invasive fungal infection.

Stockholm, Sweden – June 11, 2024 – Biosergen AB (“Biosergen”) is pleased to announce that it has received permission to test BSG005 as rescue therapy in patients with invasive fungal infections.Biosergen’s partner, Alkem Laboratories Limited (“Alkem”), has received an approval of the Clinical Trial Application and an import license from the Central Drugs Standard Control Organization (CDSCO) in India. The approval and import license allow for the initiation of the first patient trial for BSG005. A clinical trial designed to address unmet medical needs in invasive fungal infections.

Spinnova Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (Janne Poranen)

SPINNOVA PLC, COMPANY RELEASE, 11 JUNE 2024 at 1:30 p.m. EEST  Spinnova Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (Janne Poranen)     Spinnova Plc (the "Company") has received a notification on 11 June 2024, according to Chapter 9, Section 5 of the Securities Markets Act, stating that Janne Poranen’s ownership of shares exceeds 5% of all shares and votes in Spinnova Plc. Janne Poranen’s ownership exceeded the notification threshold before 19 April 2024.   The notification of exceeding the ownership

PMDS intends to carry out a rights issue of approximately SEK 27.5 million, and gives market update regarding business model

The board of directors of PMD Device Solutions AB (”PMDS” or the ”Company”),under the issue authorsation proposed to the annual general meeting on June 282024, intends to resolve on an issue of not more than 6,254,559 new shareswith preferential rights for the Company’s existing shareholders (the ”RightsIssue’’) The board of directors of PMD Device Solutions AB (”PMDS” or the ”Company”),under the issue authorsation proposed to the annual general meeting on June 282024, intends to resolve on an issue of not more than 6,254,559 new shareswith preferential rights for the

There are no items matching the current filter
There are no more items matching the current filter
Back to top